Cizzle Biotechnology Holdings PLC
LSE:CIZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cizzle Biotechnology Holdings PLC
LSE:CIZ
|
UK |
|
Samsara Luggage Inc
OTC:SAML
|
US |
Intrinsic Value
The intrinsic value of Cizzle Biotechnology Holdings PLC (CIZ) under the Base Case is 1.95 GBX per share.
Compared with the current market price of 1.15 GBX, the stock appears
Undervalued by 41% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cizzle Biotechnology Does
Cizzle Biotechnology Holdings PLC is a life sciences company focused on developing a blood test to help detect lung cancer earlier. Its core product is a diagnostic assay that looks for a protein marker linked to the disease, with the goal of giving doctors a simple test that can support screening and earlier referral for further checks. The company’s work sits in the medical diagnostics part of healthcare, where test accuracy and ease of use matter a lot.
- Headquarters
- United Kingdom UK
- Employees
- 4
- IPO date
- May 23, 2007
Earnings Waterfall
Cizzle Biotechnology Holdings PLC
The intrinsic value for Cizzle Biotechnology Holdings PLC (CIZ) under the Base Case is 1.95 GBX.
Compared with the current market price of 1.15 GBX, the stock appears Undervalued by 41% .
